An insole with a proprietary embedded graphene sensing system, passively monitors the skin’s physiological signals in order to detect early signs of foot ulcers.
Engaging providers and patients to better manage diabetes in real time.
The GlucoseMama Kit is a one-box solution to self-managing diabetes during pregnancy. It’s got everything our patients need - plus a whole lot of love!
PoC is a comprehensive health technology solution that enables post-acute care coordination at the point-of-care without the need for an additional layer and cost of care navigators.
Using mobile technology to reverse diabetes for more than half of people enrolled in our program.
For children and adults living with diabetes, influenza infections can be dangerous. The ViVI ScoreDM mobile app will help diabetic patients manage their condition better when they have the flu.
iRxReminder's IoT, pharmacy filled pill dispenser with smart alerting to improve medication adherence of mental health patients, and providing agencies monitoring and added revenue.
For people with diabetes, KingFit provides an application that delivers diabetes education from industry leading experts to the palm of your hand for free.
We help you keep track of your life, so you may become well and stay well
Palette redefines diabetes care with your own lifestyle data and rewards you with better awareness and management.
KnKt’d (App ~ Encrypted Cloud Database ~ Provider Portal) Delivers daily patient data, tracks daily treatment outcomes, and fosters treatment engagement.
Using 3D printing and genetics to biosynthesize and regenerate teeth
Important Disclosure: MedStartr.com is a website owned and operated by MedStartr, Inc., which is not a broker-dealer, funding portal or investment advisor; and neither the website nor MedStartr, Inc. participate in the offer or sale of securities. All securities related activity is conducted through Young America Capital, LLC, a registered broker-dealer and member of FINRA/SIPC. No communication, through this website, email or in any other medium, should be construed as a recommendation for any securities offering.